Home >

Publications

Selected Publications
1.   Yu-De Chu, Tan-Chi Fan, Ming-Wei Lai, Chau-Ting Yeh. GALNT14-mediated O-glycosylation on PHB2 serine-161 enhances cell growth, migration and drug resistance by activating IGF1R cascade in hepatoma cells. Cell Death Dis. 2022 Nov 14;13(11):956
2.   Ming-Wei Lai, Yao-Lung Chang, Po-Jen Cheng, Ho-Yen Chueh, Shun-Chih Chang, Chau-Ting Yeh. Absence of chronicity in infants born to immunized mothers with occult HBV infection in Taiwan. J. Hepatol. 2022 Jul;77(1):63-70.
3.   Wei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee, Ting-Jung Wu, Chen-Chun Lin, Chien-Heng Shen, Ming-Ling Chang, Chih-Lang Lin, Chau-Ting Yeh. GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trial. Hepatol Int. 2022 Jan 4. doi: 10.1007/s12072-021-10283-7. Online ahead of print.
4.   Yu-De Chu, Siew-Na Lim, Chau-Ting Yeh, Wey-Ran Lin. COX5B-Mediated Bioenergetic Alterations Modulate Cell Growth and Anticancer Drug Susceptibility by Orchestrating Claudin-2 Expression in Colorectal Cancers. Biomedicines. 2021 Dec 28;10(1):60.
5.   Yu-De Chu, Kwong-Ming Kee, Wey-Ran Lin, Ming-Wei Lai, Sheng-Nan Lu, Wen-Hung Chung, See-Tong Pang, Chau-Ting Yeh. SYNE1 Exonic Variant rs9479297 Contributes to Concurrent Hepatocellular and Transitional Cell Carcinoma Double Primary Cancer. Biomedicines. 2021 Dec 2;9(12):1819.
6.   Yang-Hsiang Lin, Meng-Han Wu, Yi-Chung Liu, Ping-Chiang Lyu, Chau-Ting Yeh and Kwang-Huei Lin. LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing. Oncogene. 2021 Jul;40(28):4075-4685.
7.   Yu-De Chu, Wey-Ran Lin, Yang-Hsiang Lin, Wen-Hsin Kuo, Chin-Ju Tseng, Siew-Na Lim, Yen-Lin Huang, Shih-Chiang Huang, Ting-Jung Wu, Kwang-Huei Lin and Chau-Ting Yeh. COX5B-Mediated Bioenergetic Alteration Regulates Tumor Growth and Migration by Modulating AMPK-UHMK1-ERK Cascade in Hepatoma. Cancers. 2020 Jun 22;12(6):1646. doi: 10.3390/cancers12061646.
8.   Chih Lang Lin, Rong Nan Chien, Yu De Chu, Kung Hao Liang, Ya Hui Huang ,Po Yuan Ke, Kwang Huei Lin, Yang Hsiang Lin, Chau Ting Yeh. Hepatitis B virus X gene mutants emerge during antiviral therapy and increase cccDNA levels to compensate for replication suppression. Hepatol Int. 2020 Aug 7. doi: 10.1007/s12072-020-10079-1.
9.   Wey-Ran Lin, Jy-Ming Chiang , Siew-Na Lim , Ming-Yao Su , Tsung-Hsing Chen , Shu-Wei Huang , Chun-Wei Chen , Ren-Chin Wu , Chia-Lung Tsai , Yang-Hsiang Lin , Malcolm, Alison , Sen-Yung Hsieh , Jau-Song Yu , Cheng-Tang Chiu , Chau-Ting Yeh.Dynamic bioenergetic alterations in colorectal adenomatous polyps and adenocarcinomas. EBioMedicine. 2019 Jun;44:334-345. doi:10.1016/j.ebiom.2019.05.031.
10.   M.-W. Lai, K.-H. LiangC.-T. Yeh. Diverse immune responses to HBV surface epitope variants after vaccine booster in adolescents immunized in infancy. Clin Microbiol Infect. 2019 Sep;25(9):1140-1146. doi: 10.1016/j.cmi.2019.02.003.
11.   Chih-Lang Lin, Yu-De Chu, Chau-Ting Yeh. Emergence of oncogenic-enhancing hepatitis B virus X gene mutants in patients receiving suboptimal entecavir treatment. Hepatology. 2018 Dec 15. doi: 10.1002/hep.30423.
12.   Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Hsiang-Cheng Chi, Chung-Ying Tsai, Wen-Yu Chuang, Chia-Jung Yu, I-Hsiao Chung, Ching-Ying Chen, Kwang-Huei Lin. Thyroid hormone negatively regulates tumorigenesis through suppression of BC200. Endocr Relat Cancer. 2018 Dec 1;25(12):967-979. doi: 10.1530/ERC-18-0176.
13.   Yang-Hsiang Lin, Meng-Han Wu, Ya-Hui Huang, Chau-Ting Yeh, Mei-Ling Cheng, Hsiang-Cheng Chi, Chung-Ying Tsai, I-Hsiao Chung, Ching-Ying Chen, Kwang-Huei Lin. Taurine up-regulated gene 1 functions as a master regulator to coordinate glycolysis and metastasis in hepatocellular carcinoma. Hepatology. 2018 Jan;67(1):188-203. doi: 10.1002/hep.29462.